Cardiac Resynchronization Therapy Market is segmented By Product Type (CRT-Defibrillators, CRT-Pacemakers), By End User (Hospitals, Specialty Clinics,....
Market Size in USD
CAGR6.4%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 6.4% |
Market Concentration | High |
Major Players | Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK, Microport Scientific Corporation |
The cardiac resynchronization therapy (CRT) market is estimated to be valued at USD 7.45 billion in 2024 and is expected to reach USD 10.83 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. Advancements in cardiac devices along with the rising geriatric population suffering from chronic heart conditions are major factors driving the growth of this market.